SlideShare una empresa de Scribd logo
1 de 70
Descargar para leer sin conexión
NS 521 - Inflammation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acute Inflammation Acute inflammation  is a rapid response to an injurious agent that   serves to deliver mediators of host defense—leukocytes and plasma proteins—to the site of injury. Acute inflammation has three major   components: (1)  alterations in vascular caliber that lead to an increase in blood flow ; (2)  structural changes in the microvasculature that permit plasma proteins and leukocytes to leave the circulation ; and (3)  emigration of the leukocytes  from the microcirculation,  their accumulation  in the focus of injury,  and their activation  to eliminate the offending   agent
Acute inflammatory reactions are   triggered by a variety of stimuli:  •  Infections  (bacterial, viral, parasitic) and microbial toxins  •  Trauma  (blunt and penetrating)  •  Physical and chemical agents  (thermal injury, e.g., burns or frostbite; irradiation; some environmental chemicals)  •  Tissue necrosis  (from any cause)  •  Foreign bodies  (splinters, dirt, sutures)  •  Immune reactions  (also called   hypersensitivity reactions)
Acute Inflammation When a host encounters an injurious agent, such as an infectious microbe or dead cells, phagocytes that reside in all tissues try to get rid of these agents. At the same time, phagocytes and other host cells react to the presence of the foreign or abnormal substance by liberating cytokines, lipid messengers, and the various other mediators of inflammation. Some   of these mediators act on endothelial   cells in the vicinity and promote the efflux of plasma and the recruitment of circulating leukocytes to the site where the offending agent is located.
Acute Inflammation - continued As the injurious agent is eliminated and anti-inflammatory mechanisms become active, the process subsides and the host returns to a normal state of health. If the injurious agent cannot be quickly eliminated, the result may be  chronic inflammation . The recruited leukocytes are activated by the injurious agent and by locally produced mediators, and the activated leukocytes try to remove the offending agent by phagocytosis.
 
Lymphocyte and Neutrophil Monocyte
The vascular phenomena of acute inflammation are characterized by increased blood flow to the injured area, resulting mainly from arteriolar dilation and opening of capillary beds induced by mediators such as histamine. Increased vascular permeability results in the accumulation of protein-rich extravascular fluid, which forms the exudate. Plasma proteins leave the vessels, most commonly through widened interendothelial cell junctions of the venules. The redness  (rubor) , warmth  (calor) , and swelling  (tumor)  of acute inflammation are caused by the increased blood flow and edema.
Circulating leukocytes, initially predominantly neutrophils, adhere to the endothelium via adhesion molecules, transmigrate across the endothelium, and migrate to the site of injury under the influence of chemotactic agents. Leukocytes that are activated by the offending agent and by endogenous mediators may release toxic metabolites and proteases extracellularly, causing tissue damage. During the damage, and in part as a result of the liberation of prostaglandins, neuropeptides, and cytokines, one of the local symptoms is pain ( dolor ).
Changes in vascular flow and caliber begin early after injury and develop at varying rates depending on the severity of the injury. The changes occur in the following order:  •  Vasodilation .  Increased blood flow  is the cause of the heat and the redness.  Vasodilation is induced by the action of several mediators, notably histamine and nitric oxide on smooth muscle .   •  Increased permeability of the microvasculature .  •  Stasis . The loss of fluid results in concentration of red cells in small vessels and increased viscosity of the blood.
 
A hallmark of acute inflammation is increased vascular permeability  leading to the escape of a protein-rich fluid ( exudate ) into the extravascular tissue. The loss of protein from the plasma reduces the intravascular osmotic pressure and increases the osmotic pressure of the interstitial fluid. Together with the increased hydrostatic pressure owing to increased blood flow through the dilated vessels, this leads to a marked  outflow  of fluid and its accumulation in the interstitial tissue.  The net increase of extravascular fluid results in  edema .
Vascular Permeability – Leakage of Carbon Particles
EDEMA In acute inflammation,  fluid loss from vessels  with increased permeability occurs in distinct phases : (1) an immediate transient   response lasting for 30 minutes or less, mediated mainly by the actions of histamine and leukotrienes on endothelium; (2) a delayed response starting at about 2 hours and lasting for about 8 hours, mediated by kinins, complement products, and other factors; and (3) a prolonged response that is most noticeable after direct endothelial injury, for example, after burns.
 
 
The sequence of events in the journey of leukocytes from the vessel lumen to the interstitial tissue, called  extravasation , can be divided into the following steps :  1. In the lumen:  margination ,  rolling ,   and  adhesion  to endothelium. Vascular endothelium normally does not bind circulating cells or impede their passage. In inflammation, the endothelium has to be activated to permit it to bind leukocytes, as a prelude to their exit from the blood vessels.  2.  Transmigration  across the endothelium (also called  diapedesis )  3.  Migration in interstitial tissues  toward a chemotactic stimulus
 
Leukocytes Rolling Within a Venule
Neutrophil Pavementing (lining the venule)
 
Leukocyte Margination and Diapedesis
Neutrophil Transendothelial Migration (Diapedesis)
 
 
 
Table 3–2. Mediators of Acute Inflammation. – – – ++ 1   – – Oxygen radicals – – – ++ 1   – – Lysosomal proteases – – +++ +? +++ – Leukotrienes   – – +? + +++ Prostaglandins – – +++ – + – Complement 5a – +++ – – – – Complement 3b – – – – + – Complement 3a ++ – – – + + Bradykinin – – – – + + Serotonin (5–HT) – – – – +++ + Histamine Pain Opsonin Chemotaxis Sustained Immediate Vasodilation Mediator  
 
 
 
 
 
 
 
Resolution of Acute Inflammation
Table 3–4. Types of Acute Inflammation. Pyogenic bacteria, eg, staphylococci, streptococci, gram–negative bacilli, anaerobes. Exaggerated neutrophil response and liquefactive necrosis of parenchymal cells; pus formation. Marked neutrophil leukocytosis in blood. Suppurative (purulent) inflammation Toxigenic bacteria, eg, diphtheria bacillus ( Corynebacterium diphtheriae ) and  Clostridium difficile.   Necrotizing inflammation involving mucous membranes. The necrotic mucosa and inflammatory exudate form an adherent membrane on the mucosal surface. Membranous (pseudomembranous) inflammation Highly virulent organisms (bacterial, viral, fungal), eg, plague ( Yersinia pesti s), anthrax ( Bacillus anthracis ), herpes simplex encephalitis, mucormycosis.  Marked tissue necrosis and hemorrhage. Necrotizing inflammation, hemorrhagic inflammation Many virulent bacterial infections. Excess fibrin formation. Fibrinous inflammation Infections, eg, common cold (rhinovirus); allergy (eg, hay fever). Marked secretion of mucus. Catarrhal inflammation (inflammation of mucous membranes) Burns; many bacterial infections. Marked fluid exudation. Serous inflammation (inflammation in body cavities) Certain hypersensitivity immune reactions Marked edema and numerous eosinophils; eosinophilia in blood. Allergic acute inflammation Viral and rickettsial infections (immune response contributes). Paucity of neutrophils in exudate; lymphocytes and plasma cells predominant; neutropenia, lymphocytosis in blood. Acute inflammation without neutrophils Bacterial infections; response to cell necrosis of any cause. Hyperemia; exudation with fibrin and neutrophils; neutrophil leukocytosis in blood. Classic type Common Causes Features Type
 
Inflammed Lung
Suppurative or purulent inflammation  is characterized by the production of large amounts of pus or purulent exudate consisting of neutrophils, necrotic cells, and edema fluid.
Serous inflammation  is marked by the outpouring of a thin fluid that,   depending on the size of injury, is derived from either the plasma or the secretions of mesothelial cells lining the peritoneal, pleural, and pericardial cavities (called  effusion ).
FIBRINOUS INFLAMMATION With more severe injuries and the resulting greater vascular permeability, larger molecules such as fibrinogen pass the vascular barrier, and fibrin is formed and deposited in the extracellular space
An ulcer  is a local defect, or excavation, of the surface of an organ or tissue that is produced by the sloughing (shedding) of inflammatory necrotic tissue
Viral Hepatitis
Chronic Inflammation Although difficult to define precisely,  chronic inflammation  is considered to be  inflammation of prolonged duration  (weeks or months)  in which active inflammation ,  tissue destruction ,  and attempts at repair are proceeding simultaneously . Although it may follow acute inflammation, chronic inflammation frequently begins insidiously, as a low-grade,  smoldering, often asymptomatic response. This latter type of chronic inflammation is the cause of tissue damage in some of the most common and disabling human diseases, such as  rheumatoid arthritis, atherosclerosis, tuberculosis, and chronic lung diseases.
Chronic inflammation arises in the following settings:  •  Persistent infections   •  Prolonged exposure to potentially toxic agents, either exogenous or endogenous   •  Autoimmunity
In contrast to acute inflammation, which is manifested by vascular changes, edema, and predominantly neutrophilic infiltration,  chronic inflammation is characterized by:   •  Infiltration with mononuclear cells , which include macrophages, lymphocytes, and plasma cells.  •  Tissue destruction , induced by the persistent offending agent or by the inflammatory cells.  • Attempts at  healing by connective tissue replacement of damaged tissue , accomplished by proliferation of small blood vessels ( angiogenesis ) and, in particular,  fibrosis
Table 5–1. Differences between Acute and Chronic Inflammation. Frequently none; variable leukocyte changes, increased plasma immunoglobulin Neutrophil leukocytosis; lymphocytosis (in viral infections) Changes in peripheral blood Low–grade fever, weight loss, anemia Fever, often high Systemic manifestations Immune response, phagocytosis, repair Plasma factors: complement, immunoglobulins, properdin, etc; neutrophils, nonimmune phagocytosis Operative host responses + – Fibrosis (collagen deposition) + (ongoing) ,[object Object],[object Object],Tissue necrosis – + Cardinal clinical signs (redness, heat, swelling, pain) – + Fluid exudation and edema New vessel formation (granulation tissue) Active vasodilation, increased permeability Vascular changes Lymphocytes, plasma cells, macrophages, fibroblasts Neutrophils, macrophages Inflammatory cells Specific (where immune response is activated) Nonspecific Specificity Insidious Acute Onset Long (weeks to months) Short (days) Duration Chronic Acute  
The products of activated macrophages serve to eliminate injurious agents such as microbes and to initiate the process of repair, and are responsible for much of the tissue injury in chronic inflammation.  Tissue destruction is one of the hallmarks of chronic inflammation.
In short-lived inflammation, if the irritant is eliminated, macrophages eventually disappear (either dying off or making their way into the lymphatics and lymph nodes). In chronic inflammation, macrophage accumulation persists, and is mediated by different mechanisms
 
 
A granuloma is a focus of chronic inflammation consisting of a microscopic aggregation of macrophages that are transformed into epithelium-like cells surrounded by a collar of mononuclear leukocytes, principally lymphocytes and occasionally plasma cells.
Table 5–2. Common Causes of Epithelioid Cell Granulomas. – Talc, fibers (? +protein)    Foreign body (eg, in intravenous drug abuse) Nonimmunologic response   – Beryllium (? +protein)    Berylliosis 3   – Unknown    Crohn's disease 2   – Unknown    Sarcoidosis 2   ++ 1   Treponema pallidum      Syphilis – Brucella  species     Brucellosis – Coxiella burnetii  (rickettsial organism)     Q fever ++ Coccidioides immitis      Coccidioidomycosis ++ Histoplasma capsulatum      Histoplasmosis – Mycobacterium leprae      Leprosy (tuberculoid type) ++ Mycobacterium tuberculosis      Tuberculosis Immunologic response   Caseous Necrosis Antigen Disease
Lung Granuloma From Tuberculosis (Tubercle)
 
Vacuolated Macrophages in Leprosy
 
Foreign Body Granuloma
Scar Formation From a Granuloma
 
 
 
 
 
Potential Roles of Nutrition in Inflammation and Immunity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Dietary restriction impairs neutrophil exudation by reducing CD11b/CD18 expression and chemokine production.  Ikeda, S., et al. Arch Surg. 2001 Mar;136(3):297-304
Copyright restrictions may apply. Ikeda, S. et al. Arch Surg 2001;136:297-304. Circulating polymorphonuclear neutrophil (PMN) kinetics
Copyright restrictions may apply. Ikeda, S. et al. Arch Surg 2001;136:297-304. Exudative polymorphonuclear neutrophil (PMN) kinetics
Copyright restrictions may apply. Ikeda, S. et al. Arch Surg 2001;136:297-304. Correlation between CD18 expression on circulating polymorphonuclear neutrophils (PMNs) and number of exudative PMNs

Más contenido relacionado

La actualidad más candente

Lecture 6 inflammation.pptx
Lecture 6 inflammation.pptxLecture 6 inflammation.pptx
Lecture 6 inflammation.pptxKizito Robert
 
Type II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic HypersensitivityType II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic HypersensitivityAnup Bajracharya
 
Mechanisms of autoimmunity
Mechanisms of autoimmunityMechanisms of autoimmunity
Mechanisms of autoimmunityahmet varis
 
Hyper sensitivity reaction type I and type II
Hyper sensitivity reaction type I and type IIHyper sensitivity reaction type I and type II
Hyper sensitivity reaction type I and type IIBharathidasan university
 
Cytokine and chemokines ppt
Cytokine and chemokines pptCytokine and chemokines ppt
Cytokine and chemokines pptManmohan09
 
Hypersensitivity reactions
Hypersensitivity reactionsHypersensitivity reactions
Hypersensitivity reactionsVarshaBarethiya
 
Acute And Chronic Inflammation
Acute And Chronic InflammationAcute And Chronic Inflammation
Acute And Chronic Inflammationaxix
 
Cells of the immune system ppt
Cells of the immune system pptCells of the immune system ppt
Cells of the immune system pptGloria Okenze
 
Defects in innate immunity
Defects in innate immunityDefects in innate immunity
Defects in innate immunitySilah Aysha
 
Wounds, healing and tissue repair
Wounds, healing and tissue repairWounds, healing and tissue repair
Wounds, healing and tissue repairImanIbrahim25
 

La actualidad más candente (20)

Lecture 6 inflammation.pptx
Lecture 6 inflammation.pptxLecture 6 inflammation.pptx
Lecture 6 inflammation.pptx
 
Type II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic HypersensitivityType II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
 
Mechanisms of autoimmunity
Mechanisms of autoimmunityMechanisms of autoimmunity
Mechanisms of autoimmunity
 
Hyper sensitivity reaction type I and type II
Hyper sensitivity reaction type I and type IIHyper sensitivity reaction type I and type II
Hyper sensitivity reaction type I and type II
 
Inflammation
InflammationInflammation
Inflammation
 
Cytokines
Cytokines Cytokines
Cytokines
 
Cytokine and chemokines ppt
Cytokine and chemokines pptCytokine and chemokines ppt
Cytokine and chemokines ppt
 
Toll-like receptors
Toll-like receptors Toll-like receptors
Toll-like receptors
 
CHRONIC INFLAMMATION
CHRONIC INFLAMMATIONCHRONIC INFLAMMATION
CHRONIC INFLAMMATION
 
Hypersensitivity reactions
Hypersensitivity reactionsHypersensitivity reactions
Hypersensitivity reactions
 
Oncogenic viruses
Oncogenic virusesOncogenic viruses
Oncogenic viruses
 
Toll like receptors
Toll like receptors   Toll like receptors
Toll like receptors
 
11,12
11,1211,12
11,12
 
Acute And Chronic Inflammation
Acute And Chronic InflammationAcute And Chronic Inflammation
Acute And Chronic Inflammation
 
Cells of the immune system ppt
Cells of the immune system pptCells of the immune system ppt
Cells of the immune system ppt
 
Defects in innate immunity
Defects in innate immunityDefects in innate immunity
Defects in innate immunity
 
Interleukins
InterleukinsInterleukins
Interleukins
 
Wounds, healing and tissue repair
Wounds, healing and tissue repairWounds, healing and tissue repair
Wounds, healing and tissue repair
 
Herpesviruses
HerpesvirusesHerpesviruses
Herpesviruses
 
Inflammation
InflammationInflammation
Inflammation
 

Destacado (20)

Humoral immunity
Humoral immunityHumoral immunity
Humoral immunity
 
Lipid metabolism
Lipid  metabolismLipid  metabolism
Lipid metabolism
 
What is stress
What is stressWhat is stress
What is stress
 
Cell biology journal abstract and summary
Cell biology journal abstract and summary Cell biology journal abstract and summary
Cell biology journal abstract and summary
 
Circulatory system handout
Circulatory system handoutCirculatory system handout
Circulatory system handout
 
Storage Devices
Storage DevicesStorage Devices
Storage Devices
 
Inflammation part 1 by
Inflammation  part 1 byInflammation  part 1 by
Inflammation part 1 by
 
Lecture notes 3
Lecture notes 3Lecture notes 3
Lecture notes 3
 
Margins and apices
Margins and apicesMargins and apices
Margins and apices
 
Rocks and minerals
Rocks and mineralsRocks and minerals
Rocks and minerals
 
Blood respiratory function & jaundice
Blood respiratory function & jaundiceBlood respiratory function & jaundice
Blood respiratory function & jaundice
 
Bio 160 Parasitology - First prelim handouts Amoeba
Bio 160 Parasitology - First prelim handouts AmoebaBio 160 Parasitology - First prelim handouts Amoeba
Bio 160 Parasitology - First prelim handouts Amoeba
 
Mitosis Cell division and general genetics
Mitosis Cell division and general geneticsMitosis Cell division and general genetics
Mitosis Cell division and general genetics
 
Crebs cycle 2013
Crebs cycle 2013Crebs cycle 2013
Crebs cycle 2013
 
diabetes
diabetesdiabetes
diabetes
 
Hormones 2
Hormones 2Hormones 2
Hormones 2
 
Pathophysiology of lipid metabolism
Pathophysiology of lipid metabolismPathophysiology of lipid metabolism
Pathophysiology of lipid metabolism
 
The Vikings
The VikingsThe Vikings
The Vikings
 
The Vikings
The VikingsThe Vikings
The Vikings
 
Nematodes trematodes and cestodes handouts
Nematodes trematodes and cestodes handoutsNematodes trematodes and cestodes handouts
Nematodes trematodes and cestodes handouts
 

Similar a Inflammation Part (2)

LECTURE 5 INFLAMMATION.pptx
LECTURE 5 INFLAMMATION.pptxLECTURE 5 INFLAMMATION.pptx
LECTURE 5 INFLAMMATION.pptxsaad510479
 
Process of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxProcess of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxShikhaSachde
 
inflammation lecture cmlt.pptx
inflammation lecture cmlt.pptxinflammation lecture cmlt.pptx
inflammation lecture cmlt.pptxwaheeda14
 
inflammation lecture cmlt.pptx
inflammation lecture cmlt.pptxinflammation lecture cmlt.pptx
inflammation lecture cmlt.pptxwaheeda14
 
Inflammation: Introduction
Inflammation: Introduction Inflammation: Introduction
Inflammation: Introduction Dr Alok Tripathi
 
Acute and chronic inflammation
Acute and chronic inflammationAcute and chronic inflammation
Acute and chronic inflammationAj Cocjin
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptxPlexDon
 
Inflammation notes Pathophysiology
Inflammation  notes PathophysiologyInflammation  notes Pathophysiology
Inflammation notes PathophysiologyBAVAMH
 
.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptxGALIBOIBRAHIM
 
Inflammation (Acute and Chronic) Prof Mulazim Hussain Bukhari
Inflammation (Acute and Chronic) Prof Mulazim Hussain BukhariInflammation (Acute and Chronic) Prof Mulazim Hussain Bukhari
Inflammation (Acute and Chronic) Prof Mulazim Hussain BukhariMulazim Bukhari
 
Inflammation and Repair
Inflammation and RepairInflammation and Repair
Inflammation and RepairNavid J. Ayon
 
Inflammation and repair
Inflammation and repairInflammation and repair
Inflammation and repairProtik Biswas
 
Inflammation by suraj chhetri
Inflammation by suraj chhetriInflammation by suraj chhetri
Inflammation by suraj chhetriSuraj Chhetri
 
4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptx4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptxByamugishaJames
 
Inflammation (2).pptx
Inflammation (2).pptxInflammation (2).pptx
Inflammation (2).pptxYomif3
 

Similar a Inflammation Part (2) (20)

Inflammation
InflammationInflammation
Inflammation
 
LECTURE 5 INFLAMMATION.pptx
LECTURE 5 INFLAMMATION.pptxLECTURE 5 INFLAMMATION.pptx
LECTURE 5 INFLAMMATION.pptx
 
Process of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptxProcess of Inflammation & Repair.pptx
Process of Inflammation & Repair.pptx
 
inflammation lecture cmlt.pptx
inflammation lecture cmlt.pptxinflammation lecture cmlt.pptx
inflammation lecture cmlt.pptx
 
inflammation lecture cmlt.pptx
inflammation lecture cmlt.pptxinflammation lecture cmlt.pptx
inflammation lecture cmlt.pptx
 
Inflammation: Introduction
Inflammation: Introduction Inflammation: Introduction
Inflammation: Introduction
 
Acute and chronic inflammation
Acute and chronic inflammationAcute and chronic inflammation
Acute and chronic inflammation
 
Inflammation
InflammationInflammation
Inflammation
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
Inflammation notes Pathophysiology
Inflammation  notes PathophysiologyInflammation  notes Pathophysiology
Inflammation notes Pathophysiology
 
MID2163 TOPIC 3
MID2163 TOPIC 3MID2163 TOPIC 3
MID2163 TOPIC 3
 
.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx.INFLAMMATION 1.pptx
.INFLAMMATION 1.pptx
 
Inflammation (Acute and Chronic) Prof Mulazim Hussain Bukhari
Inflammation (Acute and Chronic) Prof Mulazim Hussain BukhariInflammation (Acute and Chronic) Prof Mulazim Hussain Bukhari
Inflammation (Acute and Chronic) Prof Mulazim Hussain Bukhari
 
Inflammation and Repair
Inflammation and RepairInflammation and Repair
Inflammation and Repair
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
Inflammation and repair
Inflammation and repairInflammation and repair
Inflammation and repair
 
Inflammation by suraj chhetri
Inflammation by suraj chhetriInflammation by suraj chhetri
Inflammation by suraj chhetri
 
4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptx4. acute Inflammation31.08.17 153 series.pptx
4. acute Inflammation31.08.17 153 series.pptx
 
Inflammation (2).pptx
Inflammation (2).pptxInflammation (2).pptx
Inflammation (2).pptx
 

Más de hussamdr

Pathology healing and repair
Pathology healing and repairPathology healing and repair
Pathology healing and repairhussamdr
 
Inflammation Part 2
Inflammation Part 2Inflammation Part 2
Inflammation Part 2hussamdr
 
Informational macromolecules (2)
Informational macromolecules (2)Informational macromolecules (2)
Informational macromolecules (2)hussamdr
 
Fluid and electrolytes
Fluid and electrolytesFluid and electrolytes
Fluid and electrolyteshussamdr
 
Biological oxidation
Biological oxidationBiological oxidation
Biological oxidationhussamdr
 
Informational macromolecules (2)
Informational macromolecules (2)Informational macromolecules (2)
Informational macromolecules (2)hussamdr
 
Biological oxidation
Biological oxidationBiological oxidation
Biological oxidationhussamdr
 

Más de hussamdr (8)

Pathology healing and repair
Pathology healing and repairPathology healing and repair
Pathology healing and repair
 
Inflammation Part 2
Inflammation Part 2Inflammation Part 2
Inflammation Part 2
 
Informational macromolecules (2)
Informational macromolecules (2)Informational macromolecules (2)
Informational macromolecules (2)
 
Fluid and electrolytes
Fluid and electrolytesFluid and electrolytes
Fluid and electrolytes
 
Biological oxidation
Biological oxidationBiological oxidation
Biological oxidation
 
Dm
DmDm
Dm
 
Informational macromolecules (2)
Informational macromolecules (2)Informational macromolecules (2)
Informational macromolecules (2)
 
Biological oxidation
Biological oxidationBiological oxidation
Biological oxidation
 

Último

Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Adtran
 
Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024D Cloud Solutions
 
OpenShift Commons Paris - Choose Your Own Observability Adventure
OpenShift Commons Paris - Choose Your Own Observability AdventureOpenShift Commons Paris - Choose Your Own Observability Adventure
OpenShift Commons Paris - Choose Your Own Observability AdventureEric D. Schabell
 
Designing A Time bound resource download URL
Designing A Time bound resource download URLDesigning A Time bound resource download URL
Designing A Time bound resource download URLRuncy Oommen
 
NIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 WorkshopNIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 WorkshopBachir Benyammi
 
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...Aggregage
 
Videogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdfVideogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdfinfogdgmi
 
Crea il tuo assistente AI con lo Stregatto (open source python framework)
Crea il tuo assistente AI con lo Stregatto (open source python framework)Crea il tuo assistente AI con lo Stregatto (open source python framework)
Crea il tuo assistente AI con lo Stregatto (open source python framework)Commit University
 
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve DecarbonizationUsing IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve DecarbonizationIES VE
 
UiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPathCommunity
 
UiPath Platform: The Backend Engine Powering Your Automation - Session 1
UiPath Platform: The Backend Engine Powering Your Automation - Session 1UiPath Platform: The Backend Engine Powering Your Automation - Session 1
UiPath Platform: The Backend Engine Powering Your Automation - Session 1DianaGray10
 
AI Fame Rush Review – Virtual Influencer Creation In Just Minutes
AI Fame Rush Review – Virtual Influencer Creation In Just MinutesAI Fame Rush Review – Virtual Influencer Creation In Just Minutes
AI Fame Rush Review – Virtual Influencer Creation In Just MinutesMd Hossain Ali
 
Nanopower In Semiconductor Industry.pdf
Nanopower  In Semiconductor Industry.pdfNanopower  In Semiconductor Industry.pdf
Nanopower In Semiconductor Industry.pdfPedro Manuel
 
VoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBXVoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBXTarek Kalaji
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Will Schroeder
 
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online CollaborationCOMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online Collaborationbruanjhuli
 
UiPath Solutions Management Preview - Northern CA Chapter - March 22.pdf
UiPath Solutions Management Preview - Northern CA Chapter - March 22.pdfUiPath Solutions Management Preview - Northern CA Chapter - March 22.pdf
UiPath Solutions Management Preview - Northern CA Chapter - March 22.pdfDianaGray10
 
Igniting Next Level Productivity with AI-Infused Data Integration Workflows
Igniting Next Level Productivity with AI-Infused Data Integration WorkflowsIgniting Next Level Productivity with AI-Infused Data Integration Workflows
Igniting Next Level Productivity with AI-Infused Data Integration WorkflowsSafe Software
 
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDEADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDELiveplex
 

Último (20)

Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™
 
Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024Artificial Intelligence & SEO Trends for 2024
Artificial Intelligence & SEO Trends for 2024
 
OpenShift Commons Paris - Choose Your Own Observability Adventure
OpenShift Commons Paris - Choose Your Own Observability AdventureOpenShift Commons Paris - Choose Your Own Observability Adventure
OpenShift Commons Paris - Choose Your Own Observability Adventure
 
Designing A Time bound resource download URL
Designing A Time bound resource download URLDesigning A Time bound resource download URL
Designing A Time bound resource download URL
 
NIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 WorkshopNIST Cybersecurity Framework (CSF) 2.0 Workshop
NIST Cybersecurity Framework (CSF) 2.0 Workshop
 
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
 
Videogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdfVideogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdf
 
Crea il tuo assistente AI con lo Stregatto (open source python framework)
Crea il tuo assistente AI con lo Stregatto (open source python framework)Crea il tuo assistente AI con lo Stregatto (open source python framework)
Crea il tuo assistente AI con lo Stregatto (open source python framework)
 
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve DecarbonizationUsing IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
 
UiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation DevelopersUiPath Community: AI for UiPath Automation Developers
UiPath Community: AI for UiPath Automation Developers
 
UiPath Platform: The Backend Engine Powering Your Automation - Session 1
UiPath Platform: The Backend Engine Powering Your Automation - Session 1UiPath Platform: The Backend Engine Powering Your Automation - Session 1
UiPath Platform: The Backend Engine Powering Your Automation - Session 1
 
AI Fame Rush Review – Virtual Influencer Creation In Just Minutes
AI Fame Rush Review – Virtual Influencer Creation In Just MinutesAI Fame Rush Review – Virtual Influencer Creation In Just Minutes
AI Fame Rush Review – Virtual Influencer Creation In Just Minutes
 
Nanopower In Semiconductor Industry.pdf
Nanopower  In Semiconductor Industry.pdfNanopower  In Semiconductor Industry.pdf
Nanopower In Semiconductor Industry.pdf
 
VoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBXVoIP Service and Marketing using Odoo and Asterisk PBX
VoIP Service and Marketing using Odoo and Asterisk PBX
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
 
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online CollaborationCOMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
 
UiPath Solutions Management Preview - Northern CA Chapter - March 22.pdf
UiPath Solutions Management Preview - Northern CA Chapter - March 22.pdfUiPath Solutions Management Preview - Northern CA Chapter - March 22.pdf
UiPath Solutions Management Preview - Northern CA Chapter - March 22.pdf
 
Igniting Next Level Productivity with AI-Infused Data Integration Workflows
Igniting Next Level Productivity with AI-Infused Data Integration WorkflowsIgniting Next Level Productivity with AI-Infused Data Integration Workflows
Igniting Next Level Productivity with AI-Infused Data Integration Workflows
 
20230104 - machine vision
20230104 - machine vision20230104 - machine vision
20230104 - machine vision
 
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDEADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
ADOPTING WEB 3 FOR YOUR BUSINESS: A STEP-BY-STEP GUIDE
 

Inflammation Part (2)

  • 1.
  • 2. Acute Inflammation Acute inflammation is a rapid response to an injurious agent that serves to deliver mediators of host defense—leukocytes and plasma proteins—to the site of injury. Acute inflammation has three major components: (1) alterations in vascular caliber that lead to an increase in blood flow ; (2) structural changes in the microvasculature that permit plasma proteins and leukocytes to leave the circulation ; and (3) emigration of the leukocytes from the microcirculation, their accumulation in the focus of injury, and their activation to eliminate the offending agent
  • 3. Acute inflammatory reactions are triggered by a variety of stimuli: • Infections (bacterial, viral, parasitic) and microbial toxins • Trauma (blunt and penetrating) • Physical and chemical agents (thermal injury, e.g., burns or frostbite; irradiation; some environmental chemicals) • Tissue necrosis (from any cause) • Foreign bodies (splinters, dirt, sutures) • Immune reactions (also called hypersensitivity reactions)
  • 4. Acute Inflammation When a host encounters an injurious agent, such as an infectious microbe or dead cells, phagocytes that reside in all tissues try to get rid of these agents. At the same time, phagocytes and other host cells react to the presence of the foreign or abnormal substance by liberating cytokines, lipid messengers, and the various other mediators of inflammation. Some of these mediators act on endothelial cells in the vicinity and promote the efflux of plasma and the recruitment of circulating leukocytes to the site where the offending agent is located.
  • 5. Acute Inflammation - continued As the injurious agent is eliminated and anti-inflammatory mechanisms become active, the process subsides and the host returns to a normal state of health. If the injurious agent cannot be quickly eliminated, the result may be chronic inflammation . The recruited leukocytes are activated by the injurious agent and by locally produced mediators, and the activated leukocytes try to remove the offending agent by phagocytosis.
  • 6.  
  • 8. The vascular phenomena of acute inflammation are characterized by increased blood flow to the injured area, resulting mainly from arteriolar dilation and opening of capillary beds induced by mediators such as histamine. Increased vascular permeability results in the accumulation of protein-rich extravascular fluid, which forms the exudate. Plasma proteins leave the vessels, most commonly through widened interendothelial cell junctions of the venules. The redness (rubor) , warmth (calor) , and swelling (tumor) of acute inflammation are caused by the increased blood flow and edema.
  • 9. Circulating leukocytes, initially predominantly neutrophils, adhere to the endothelium via adhesion molecules, transmigrate across the endothelium, and migrate to the site of injury under the influence of chemotactic agents. Leukocytes that are activated by the offending agent and by endogenous mediators may release toxic metabolites and proteases extracellularly, causing tissue damage. During the damage, and in part as a result of the liberation of prostaglandins, neuropeptides, and cytokines, one of the local symptoms is pain ( dolor ).
  • 10. Changes in vascular flow and caliber begin early after injury and develop at varying rates depending on the severity of the injury. The changes occur in the following order: • Vasodilation . Increased blood flow is the cause of the heat and the redness. Vasodilation is induced by the action of several mediators, notably histamine and nitric oxide on smooth muscle . • Increased permeability of the microvasculature . • Stasis . The loss of fluid results in concentration of red cells in small vessels and increased viscosity of the blood.
  • 11.  
  • 12. A hallmark of acute inflammation is increased vascular permeability leading to the escape of a protein-rich fluid ( exudate ) into the extravascular tissue. The loss of protein from the plasma reduces the intravascular osmotic pressure and increases the osmotic pressure of the interstitial fluid. Together with the increased hydrostatic pressure owing to increased blood flow through the dilated vessels, this leads to a marked outflow of fluid and its accumulation in the interstitial tissue. The net increase of extravascular fluid results in edema .
  • 13. Vascular Permeability – Leakage of Carbon Particles
  • 14. EDEMA In acute inflammation, fluid loss from vessels with increased permeability occurs in distinct phases : (1) an immediate transient response lasting for 30 minutes or less, mediated mainly by the actions of histamine and leukotrienes on endothelium; (2) a delayed response starting at about 2 hours and lasting for about 8 hours, mediated by kinins, complement products, and other factors; and (3) a prolonged response that is most noticeable after direct endothelial injury, for example, after burns.
  • 15.  
  • 16.  
  • 17. The sequence of events in the journey of leukocytes from the vessel lumen to the interstitial tissue, called extravasation , can be divided into the following steps : 1. In the lumen: margination , rolling , and adhesion to endothelium. Vascular endothelium normally does not bind circulating cells or impede their passage. In inflammation, the endothelium has to be activated to permit it to bind leukocytes, as a prelude to their exit from the blood vessels. 2. Transmigration across the endothelium (also called diapedesis ) 3. Migration in interstitial tissues toward a chemotactic stimulus
  • 18.  
  • 21.  
  • 24.  
  • 25.  
  • 26.  
  • 27. Table 3–2. Mediators of Acute Inflammation. – – – ++ 1   – – Oxygen radicals – – – ++ 1   – – Lysosomal proteases – – +++ +? +++ – Leukotrienes   – – +? + +++ Prostaglandins – – +++ – + – Complement 5a – +++ – – – – Complement 3b – – – – + – Complement 3a ++ – – – + + Bradykinin – – – – + + Serotonin (5–HT) – – – – +++ + Histamine Pain Opsonin Chemotaxis Sustained Immediate Vasodilation Mediator  
  • 28.  
  • 29.  
  • 30.  
  • 31.  
  • 32.  
  • 33.  
  • 34.  
  • 35. Resolution of Acute Inflammation
  • 36. Table 3–4. Types of Acute Inflammation. Pyogenic bacteria, eg, staphylococci, streptococci, gram–negative bacilli, anaerobes. Exaggerated neutrophil response and liquefactive necrosis of parenchymal cells; pus formation. Marked neutrophil leukocytosis in blood. Suppurative (purulent) inflammation Toxigenic bacteria, eg, diphtheria bacillus ( Corynebacterium diphtheriae ) and Clostridium difficile.   Necrotizing inflammation involving mucous membranes. The necrotic mucosa and inflammatory exudate form an adherent membrane on the mucosal surface. Membranous (pseudomembranous) inflammation Highly virulent organisms (bacterial, viral, fungal), eg, plague ( Yersinia pesti s), anthrax ( Bacillus anthracis ), herpes simplex encephalitis, mucormycosis.  Marked tissue necrosis and hemorrhage. Necrotizing inflammation, hemorrhagic inflammation Many virulent bacterial infections. Excess fibrin formation. Fibrinous inflammation Infections, eg, common cold (rhinovirus); allergy (eg, hay fever). Marked secretion of mucus. Catarrhal inflammation (inflammation of mucous membranes) Burns; many bacterial infections. Marked fluid exudation. Serous inflammation (inflammation in body cavities) Certain hypersensitivity immune reactions Marked edema and numerous eosinophils; eosinophilia in blood. Allergic acute inflammation Viral and rickettsial infections (immune response contributes). Paucity of neutrophils in exudate; lymphocytes and plasma cells predominant; neutropenia, lymphocytosis in blood. Acute inflammation without neutrophils Bacterial infections; response to cell necrosis of any cause. Hyperemia; exudation with fibrin and neutrophils; neutrophil leukocytosis in blood. Classic type Common Causes Features Type
  • 37.  
  • 39. Suppurative or purulent inflammation is characterized by the production of large amounts of pus or purulent exudate consisting of neutrophils, necrotic cells, and edema fluid.
  • 40. Serous inflammation is marked by the outpouring of a thin fluid that, depending on the size of injury, is derived from either the plasma or the secretions of mesothelial cells lining the peritoneal, pleural, and pericardial cavities (called effusion ).
  • 41. FIBRINOUS INFLAMMATION With more severe injuries and the resulting greater vascular permeability, larger molecules such as fibrinogen pass the vascular barrier, and fibrin is formed and deposited in the extracellular space
  • 42. An ulcer is a local defect, or excavation, of the surface of an organ or tissue that is produced by the sloughing (shedding) of inflammatory necrotic tissue
  • 44. Chronic Inflammation Although difficult to define precisely, chronic inflammation is considered to be inflammation of prolonged duration (weeks or months) in which active inflammation , tissue destruction , and attempts at repair are proceeding simultaneously . Although it may follow acute inflammation, chronic inflammation frequently begins insidiously, as a low-grade, smoldering, often asymptomatic response. This latter type of chronic inflammation is the cause of tissue damage in some of the most common and disabling human diseases, such as rheumatoid arthritis, atherosclerosis, tuberculosis, and chronic lung diseases.
  • 45. Chronic inflammation arises in the following settings: • Persistent infections • Prolonged exposure to potentially toxic agents, either exogenous or endogenous • Autoimmunity
  • 46. In contrast to acute inflammation, which is manifested by vascular changes, edema, and predominantly neutrophilic infiltration, chronic inflammation is characterized by: • Infiltration with mononuclear cells , which include macrophages, lymphocytes, and plasma cells. • Tissue destruction , induced by the persistent offending agent or by the inflammatory cells. • Attempts at healing by connective tissue replacement of damaged tissue , accomplished by proliferation of small blood vessels ( angiogenesis ) and, in particular, fibrosis
  • 47.
  • 48. The products of activated macrophages serve to eliminate injurious agents such as microbes and to initiate the process of repair, and are responsible for much of the tissue injury in chronic inflammation. Tissue destruction is one of the hallmarks of chronic inflammation.
  • 49. In short-lived inflammation, if the irritant is eliminated, macrophages eventually disappear (either dying off or making their way into the lymphatics and lymph nodes). In chronic inflammation, macrophage accumulation persists, and is mediated by different mechanisms
  • 50.  
  • 51.  
  • 52. A granuloma is a focus of chronic inflammation consisting of a microscopic aggregation of macrophages that are transformed into epithelium-like cells surrounded by a collar of mononuclear leukocytes, principally lymphocytes and occasionally plasma cells.
  • 53. Table 5–2. Common Causes of Epithelioid Cell Granulomas. – Talc, fibers (? +protein)    Foreign body (eg, in intravenous drug abuse) Nonimmunologic response   – Beryllium (? +protein)    Berylliosis 3   – Unknown    Crohn's disease 2   – Unknown    Sarcoidosis 2   ++ 1   Treponema pallidum      Syphilis – Brucella species     Brucellosis – Coxiella burnetii (rickettsial organism)     Q fever ++ Coccidioides immitis      Coccidioidomycosis ++ Histoplasma capsulatum      Histoplasmosis – Mycobacterium leprae      Leprosy (tuberculoid type) ++ Mycobacterium tuberculosis      Tuberculosis Immunologic response   Caseous Necrosis Antigen Disease
  • 54. Lung Granuloma From Tuberculosis (Tubercle)
  • 55.  
  • 57.  
  • 59. Scar Formation From a Granuloma
  • 60.  
  • 61.  
  • 62.  
  • 63.  
  • 64.  
  • 65.
  • 66.  
  • 67. Dietary restriction impairs neutrophil exudation by reducing CD11b/CD18 expression and chemokine production. Ikeda, S., et al. Arch Surg. 2001 Mar;136(3):297-304
  • 68. Copyright restrictions may apply. Ikeda, S. et al. Arch Surg 2001;136:297-304. Circulating polymorphonuclear neutrophil (PMN) kinetics
  • 69. Copyright restrictions may apply. Ikeda, S. et al. Arch Surg 2001;136:297-304. Exudative polymorphonuclear neutrophil (PMN) kinetics
  • 70. Copyright restrictions may apply. Ikeda, S. et al. Arch Surg 2001;136:297-304. Correlation between CD18 expression on circulating polymorphonuclear neutrophils (PMNs) and number of exudative PMNs